Ekso Bionics Holdings, Inc. (EKSO): Analyzing Basic Trading Data

In the past 52-week period, shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) have moved within the range of $0.99 to $4.77. On the stock’s most recent trading day, the company’s shares ended the regular session at $2.05, which is 57.02% higher than its 52-week high.

Ekso Bionics Holdings, Inc. (EKSO) has demonstrated a 20-day simple moving average (SMA) of -14.81%, and a 50-day SMA of 1.10%. This public company’s current market capitalization stands at $128.58 million.

Analyzing Consensus Estimates, Sales Revenue and Net Income

When thinking about buying shares in a public company, it is useful to gauge the average enthusiasm level of Wall Street analysts for that specific stock. According to the latest data, the consensus recommendation for Ekso Bionics Holdings, Inc. (EKSO) is Outperform.

When it comes to quarterly financial results, publicly-traded companies usually post earnings and revenue figures that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Ekso Bionics Holdings, Inc. (EKSO) delivered a 33.38% surprise with its net revenue.

Ownership at Ekso Bionics Holdings, Inc. (EKSO), According to Most Recent SEC Filings

Investors can gain useful insight on institutional ownership within a public company by taking a look at the organization’s most recent 13F filings. Ekso Bionics Holdings, Inc. (EKSO) has 0 billion shares outstanding currently, 06.22% of which belong to institutional investors. Those institutional holdings amount to $0.01 billion.

Additionally, according to the most recent 13F filing from Ekso Bionics Holdings, Inc. (EKSO), there were 7 new positions totaling 1,175,164 shares of the company’s stock. There were 3 sold out positions, on the other hand, totaling 19,701 shares.

Short, Medium and Long Term Indicators

By looking at a stock’s average trade volume – in the short, medium, and long terms – we can gain a better understanding of investor sentiment and trading activity. Ekso Bionics Holdings, Inc. (EKSO) has had a 20-day average volume of 1,506,630 shares, with an average of 40% of short term indicators pointed at Sell.

The stock’s 50-day average volume has been 2,770,638 shares, with an average of 0% of medium term indicators pointing toward Hold. Finally, its 100-day average volume is 1,654,059 shares with 67% of long-term indicators pointing to Buy.